Kymera Therapeutics
KYMR
KYMR
164 hedge funds and large institutions have $2.7B invested in Kymera Therapeutics in 2024 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 58 increasing their positions, 45 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% more funds holding
Funds holding: 136 → 164 (+28)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
0.28% more ownership
Funds ownership: 109.74% → 110.02% (+0.28%)
Holders
164
Holding in Top 10
7
Calls
$2.73M
Puts
$740K
Top Buyers
| 1 | +$154M | |
| 2 | +$50.7M | |
| 3 | +$40.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$31.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.9M |
Top Sellers
| 1 | -$33M | |
| 2 | -$21M | |
| 3 | -$19.8M | |
| 4 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
-$19.3M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$15.5M |